Ibudilast is a prostacyclin-mediated vasodilator and antiplatelet agent. The hemodynamic effects of ibudilast were evaluated in 41 patients with non-insulin-dependent diabetes mellitus by means of two-dimensional Doppler ultrasonography and laser Doppler blood flowmetry. Before and one hour after oral administration of ibudilast (10 mg), or elastase (1800 U) as a control, the cross-sectional area (CSA) of the dorsal pedis artery, its blood flow index (BFI), and dermal microcirculatory blood volume (MBV) were measured. In the ibudilast group, all of the parameters (CSA, BFI, and MBV) significantly increased as compared with the elastase group. These data suggest that ibudilast is effective in amelio rating diabetic macroangiopathy and microangiopathy of the lower limbs.
Get full access to this article
View all access options for this article.
References
1.
Nagai H., Iwamoto T., Nishiyori T., et al: Pharmacological studies on newly synthesized anti-allergic agents, 2-methyl-3-piperidino-β-propionaphtone hydrochloride (KZ-111) and 3-isobutyryl-2-isopropylpyrazolo-[1,5a]-pyridine(KC-404) . Jpn J Pharmacol33:1215-1223, 1983 .
2.
Ohashi M., Kanai R., Nishino K., et al: Antagonistic effect of KC-404, a new anti-asthmatic agent, on leukotriene D4-induced contractile responses in isolated guinea pig smooth muscles. Prostaglandins32:875-888, 1986.
3.
Ohashi M., Kito J., Nishino K.: Mode of cerebral vasodilating action of KC-404 in isolated canine basilar artery. Arch Int Pharmacodyn280:216-229, 1986.
4.
Armsted WM, Mirro R., Leffler CW, et al: The role of prostanoids in the mediation of responses to KC-404, a novel cerebrovasodilator. J Pharmacol Exp Ther244:138-143, 1988.
5.
Hisayama T., Takayanagi I., Goromaru N., et al: Potentiating effect of 3-isobutyryl-2-isopropylpyrazolo-[1,5a]-pyridine (KC-404), a new cerebral vasodilator with anti-platelet activity, on prostacyclineinduced increase of cyclic AMP content in platelets of rat. Gen Pharmacol20:183-186, 1984.
6.
Ohashi M., Ohkubo M., Kito J., et al: A new vasodilator 3-isobutyryl-2-isopropylpyrazolo [1,5-a] pyridine (KC-404) has a dual mechanism of action on platelet aggregation. Arch Int Pharmacodyn283:321-334, 1986.
7.
Tsuchiya Y., Uno E., Minamide N., et al: Study of the clinical usefulness of ibudilast (Ketas®) in the treatment of cerebral angiopathy, particularly in cases of long-term administration . Shinyaku to Rinsho (Journal of New Remedies Clinics)40:912-924, 1991 (Japanese).
8.
Boku K., Katsuyama A., Mori H., et al: The effect of ibudilast on diabetic peripheral neuropathy. Yakuri to Chiryo (Basic Pharmacology and Therapeutics)19:2033-2037, 1991 (Japanese, abstract in English).
9.
Honda H., Watabe K., Katayama M., et al: Effect of ibudilast (Ketas®) on blood rheology factors in cases of chronic penetrating branch type cerebral infarction. Rinsho Seijinbyo (The Journal of Adult Diseases)21:1015-1020, 1991 (Japanese).
10.
Yoneyama K. , Horiuchi M., Saito K., et al: Effect of ibudilast on cerebral circulation of cerebral angiopathy patients—A study of total carotid artery blood flow volume and middle cerebral artery blood flow rate . Prog Med12:1345-1350, 1992 (Japanese).
11.
Yoshida S.: Effect of KC-404 on internal carotid artery blood flow. Kiso to Rinsho17:2015-2021, 1989 (Japanese).
12.
Tamura T., Okamoto F., Sato R., et al: Effect of ibudilast on guinea pig cochlear blood flow. Kiso to Rinsho (Laboratory and Clinics)25:2675-2677, 1991 (Japanese).
13.
Terasawa K. , Sasaki O.: Clinical effect on Meniere's disease by ibudilast . Jibi Rinsho (Practica Otologica, Kyoto) 83:1873-1883, 1990 (Japanese, abstract in English).
14.
Sugihara I. , Ishibashi K., Furuya S., et al: Effect of per-oral ibudilast on the retinal circulation in diabetic eyes. Rinsho Ganka (Jpn J Clin Ophthalmol)46:559-562, 1992 (Japanese, abstract in English).
15.
Kappen CW, Pritchard KA, Arnold JH, et al: Restoration of prostacyclin/thromboxane A2 balance in the diabetic rat. Diabetes31:947-951, 1982.
16.
Coffman JD: Intermittent claudication—Be conservative. N Engl J Med325:577-578, 1991.
